ClearPoint Neuro, Inc.
CLPT
$12.56
-$0.62-4.70%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.32% | 3.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.32% | 3.36% | |||
| Cost of Revenue | -8.12% | 14.11% | |||
| Gross Profit | -1.75% | -2.83% | |||
| SG&A Expenses | 4.92% | 1.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.61% | 5.53% | |||
| Operating Income | -8.35% | -9.14% | |||
| Income Before Tax | -8.28% | -12.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.28% | -12.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.28% | -12.84% | |||
| EBIT | -8.35% | -9.14% | |||
| EBITDA | -9.29% | -8.92% | |||
| EPS Basic | -8.26% | -12.34% | |||
| Normalized Basic EPS | -8.25% | -12.36% | |||
| EPS Diluted | -8.26% | -12.34% | |||
| Normalized Diluted EPS | -8.25% | -12.36% | |||
| Average Basic Shares Outstanding | 0.00% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
